Skip to main content
. 2022 May 26;12(11):1365. doi: 10.3390/ani12111365

Figure 2.

Figure 2

SFN modulated PSC proliferation and myogenic transcription factors (TFs). (A): The viability of PSCs treated with Ctrl or SFN at different concentrations (5, 10, 15, or 20 μM). (B,C): qRT-PCR results of PSC proliferation and differentiation associated genes in Ctrl and SFN (10 μM) groups. Data were shown as the mean ± SE and assays were done in triplicates. * p < 0.05, ** p < 0.01, *** p < 0.001.